Effect of the thrombin receptor antagonist (PAR-1) vorapaxar on QT/QTc interval in healthy volunteers: A randomized, placebo- and positive-controlled, parallel group trial

2013 ◽  
Vol 3 (1) ◽  
pp. 18-24 ◽  
Author(s):  
Teddy Kosoglou ◽  
Thomas L. Hunt ◽  
Fengjuan Xuan ◽  
Bharath Kumar ◽  
Paul Statkevich ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document